U.S. Court of Appeals for the Federal Circuit, 2011

King Pharmaceuticals v. Eon Labs

King Pharmaceuticals v. Eon Labs
U.S. Court of Appeals for the Federal Circuit · Decided March 25, 2011

King Pharmaceuticals v. Eon Labs

Opinion

NOTE: This order is nonprecedential.

Wniteh ~tate~ ([ourt of ~peal~ for !be jfeheral ([ircuit KING PHARMACEUTICALS, INC. AND KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC., Plaintiffs / Counterclaim Defendants-Appellees, and JONES PHARMA INC., Plaintiff/Counterclaim Defendant, v. EON LABS, INC., Defendant / Counterclaim Plaintiff-Appellant, v. ELAN PHARMACEUTICALS, INC., Counterclaim Defendant-Appellee.

2011-1070

Appeal from the United States District Court for the Eastern District of New York in case no. 04-CV-5540, Senior Judge David G. Trager.

ON MOTION KING PHARMA v. EON LABS 2 ORDER Eon Labs, Inc. moves for a 14-day extension of time, until April 7, 2011, to respond to Elan Pharmaceuticals, Inc.'s Motion for Fees and Costs and for a 14-day exten- sion of time, until April 8, 2011, to file its reply brief.

Upon consideration thereof, IT Is ORDERED THAT: (1) The motions for extensions of time are granted. (2) The motion for fees and costs is deferred for con- sideration by the merits panel. Copies of this order, the motion, and any response or reply shall be transmitted to the merits panel.

FOR THE COURT MAR 25 2011 /s/ Jan Horbaly Date Jan Horbaly Clerk cc: F. Dominic Cerrito, Esq.

James B. Monroe, Esq.

Martin B. Pavane, Esq. s21 FILED U. COURT OF APPEALS FOft THE FEDE~l CIRCUIT MAR 252011

Case-law data current through December 31, 2025. Source: CourtListener bulk data.